Clinical Trials Directory

Trials / Completed

CompletedNCT00990847

Nebulized Procaterol Versus Nebule Salbutamol for the Treatment of Moderate Acute Asthma

The Efficacy of Nebulized Procaterol Versus Nebulized Salbutamol for the Treatment of Moderate Acute Asthma: a Randomized, Double-blind, Parallel Group Study

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
140 (actual)
Sponsor
PT Otsuka Indonesia · Industry
Sex
All
Age
15 Years – 60 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to compare the efficacy and safety of nebule procaterol with nebule salbutamol in the treatment of moderate acute asthma.

Conditions

Interventions

TypeNameDescription
DRUGProcaterol, Salbultamol

Timeline

Start date
2007-06-01
Primary completion
2008-04-01
Completion
2008-08-01
First posted
2009-10-07
Last updated
2009-10-07

Locations

1 site across 1 country: Indonesia

Source: ClinicalTrials.gov record NCT00990847. Inclusion in this directory is not an endorsement.

Nebulized Procaterol Versus Nebule Salbutamol for the Treatment of Moderate Acute Asthma (NCT00990847) · Clinical Trials Directory